Argo Biopharma
Jiading
About Argo Biopharma
Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $103.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: argobiopharma.com
Industries & Categories
Biotechnology, Product Research
Social Profiles
Canonical: https://fsome.com/organization/argo-biopharma-97748 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.